Perineal seeding of prostate cancer as the only evidence of clinical recurrence 14 years after needle biopsy and radical prostatectomy: Molecular correlation

Urology

Volumn 51, Issue 1, 1998, Pages 158-160

  Moul, Judd W ^a   Bauer, John J ^b   Srivastava, Shiv ^b   Colon, Edgar ^b   Ho, Chi K ^b   Sesterhenn, Isabell A ^b   McLeod, David G ^b  

^a UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACID PHOSPHATASE PROSTATE ISOENZYME; HORMONE; PROSTATE SPECIFIC ANTIGEN; PROTEIN P53;

AGED; ARTICLE; CANCER RECURRENCE; CASE REPORT; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; METASTASIS; NEEDLE BIOPSY; NUCLEAR MAGNETIC RESONANCE IMAGING; PERINEUM; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATECTOMY; TUMOR SUPPRESSOR GENE;

AGED; BIOPSY, NEEDLE; HUMANS; MALE; NEOPLASM SEEDING; PERINEUM; PROSTATECTOMY; PROSTATIC NEOPLASMS; PROTO-ONCOGENE PROTEINS C-BCL-2; TIME FACTORS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0031891706     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(97)00487-1     Document Type: Article

References (9)

1. Moul JW, Miles BJ, Skoog SJ, and McLeod DG: Risk factors for perineal seeding of prostate cancer after needle biopsy. J Urol 142: 86-88, 1989.
2. Haddad FS: Risk factors for perineal seeding of prostate cancer after needle biopsy (letter). J Urol 143: 587-588, 1990.
3. Haddad FS, and Somsin AA: Seeding and perineal implantation of prostatic cancer in the tract of the biopsy needle: three case reports and a review of the literature. J Surg Oncol 35: 184-191, 1987.
4. Desai SG, and Woodruff LM: Carcinoma of prostate: local extension following perineal needle biopsy. Urology 3: 87-88, 1974.
5. Heidenberg HB, Sesterhenn IA, Gaddipatti J, Weghorst CM, Buzard GS, Moul JW, and Srivastava S: Alterations of the tumor suppressor gene p53 in a high fraction of treatment resistant prostate cancer. J Urol 154: 414-421, 1995.
6. Bauer JJ, Sesterhenn IA, Mostofi FK, McLeod DG, Srivastava S, and Moul JW: p53 nuclear protein expression is an independent prognostic marker in clinically localized prostate cancer patients undergoing radical prostatectomy. Clin Cancer Res 1: 1295-1300, 1995.
7. Bauer JJ, Sesterhenn IA, Mostofi FK, McLeod DG, Srivastava S, and Moul JW: Elevated levels of apoptosis regulator proteins p53 and bcl-2 are independent prognostic biomarkers in surgically treated clinically localized prostate cancer patients. J Urol 156: 1511-1516, 1996.
8. McDonell TJ, Navone NM, Troncoso P, Pisters LL, Conti C, von Eschenbach AC, Brisbay S, and Logothetis CJ: Expression of bcl-2 oncoprotein and p53 protein accumulation in bone marrow metastases of androgen independent prostate cancer. J Urol 157: 569-574, 1997.
9. The Medical Research Council Prostate Cancer Working Party Investigators Group: Immediate versus deferred treatment for advanced prostatic cancer: initial results of the Medical Research Council trial. Br J Urol 79: 235-246, 1997.